{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:02:55Z","timestamp":1790708575437,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.parkreldis.2016.12.014","type":"journal-article","created":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T05:15:13Z","timestamp":1481865313000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["A \u201cdose\u201d effect of mutations in the GBA gene on Parkinson's disease phenotype"],"prefix":"10.1016","volume":"36","author":[{"given":"Avner","family":"Thaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Bar Shira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Gana Weisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Ash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Shiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Orr-Urtreger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Mirelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.parkreldis.2016.12.014_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J","article-title":"Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population","volume":"12","author":"Horowitz","year":"1998","journal-title":"Hum. Mutat."},{"issue":"17","key":"10.1016\/j.parkreldis.2016.12.014_bib2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"24","key":"10.1016\/j.parkreldis.2016.12.014_bib3","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset","volume":"70","author":"Gan-Or","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2016.12.014_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential effects of severe vs mild GBA mutations on Parkinson disease","volume":"84","author":"Gan-Or","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2016.12.014_bib5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1212\/WNL.0000000000001321","article-title":"GBA mutations and Parkinson disease: when genotype meets phenotype","volume":"84","author":"Scholz","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2016.12.014_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20228","article-title":"Familial aggregation of Parkinson's disease: the Mayo Clinic family study","volume":"56","author":"Rocca","year":"2004","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.12.014_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.neurobiolaging.2013.08.012","article-title":"Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals","volume":"35","author":"Wang","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.12.014_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.26071","article-title":"GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study","volume":"30","author":"Brockmann","year":"2015","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.12.014_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-associated PD presents with nonmotor characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.12.014_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort","volume":"72","author":"Beavan","year":"2015","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.12.014_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.parkreldis.2016.12.014_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.12.014_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2016.12.014_bib14","first-page":"85","article-title":"Gaucher disease: gene frequencies in the Ashkenazi Jewish population","volume":"52","author":"Beutler","year":"1993","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.12.014_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B","article-title":"Parkinson's syndrome preceding clinical manifestation of Gaucher's disease","volume":"61","author":"Machaczka","year":"1999","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.parkreldis.2016.12.014_bib16","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1212\/01.wnl.0000176987.47875.28","article-title":"Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation","volume":"65","author":"Aharon-Peretz","year":"2005","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2016.12.014_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000447450","article-title":"LRRK2, GBA and SMPD1 founder mutations and Parkinson's disease in Ashkenazi Jews","volume":"42","author":"Dagan","year":"2016","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"10.1016\/j.parkreldis.2016.12.014_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.23046","article-title":"Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization","volume":"25","author":"Saunders-Pullman","year":"2010","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.12.014_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcmd.2012.11.011","article-title":"Phenotype in patients with Gaucher disease and Parkinson disease","volume":"50","author":"Chetrit","year":"2013","journal-title":"Blood cells, Mol. Dis."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.12.014_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson's disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J.\u00a0Inherit. metabolic Dis."},{"issue":"10","key":"10.1016\/j.parkreldis.2016.12.014_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","article-title":"The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations","volume":"65","author":"Goker-Alpan","year":"2008","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.12.014_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","article-title":"The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry","volume":"46","author":"Rosenbloom","year":"2011","journal-title":"Blood cells, Mol. Dis."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.12.014_bib23","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1212\/NXG.0000000000000057","article-title":"Clinical course and prognosis in patients with Gaucher disease and parkinsonism","volume":"2","author":"Lopez","year":"2016","journal-title":"Neurol. Genet."},{"issue":"10","key":"10.1016\/j.parkreldis.2016.12.014_bib24","first-page":"2523","article-title":"Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease","volume":"260","author":"Bottcher","year":"2013","journal-title":"J.\u00a0Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2016.12.014_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","article-title":"Comparison of Parkinson risk in Ashkenazi Jewish patients with gaucher disease and GBA heterozygotes","volume":"71","author":"Alcalay","year":"2014","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2016.12.014_bib26","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 7","key":"10.1016\/j.parkreldis.2016.12.014_bib27","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2016.12.014_bib28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.parkreldis.2016.12.014_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A\u00a0multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016304953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016304953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:27:50Z","timestamp":1536193670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016304953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":29,"alternative-id":["S1353802016304953"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.12.014","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A \u201cdose\u201d effect of mutations in the GBA gene on Parkinson's disease phenotype","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}